Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 11:57:39 - browse：7

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： The White House hikes tariffs on plastic syringes made in China

WSS

Cherokee Nation medical school graduates its first class

Transgender sports debate: Physicians say bans are health issue

Boston hospital trains restaurant workers on naloxone for overdoses

The United States must get value

Ripples from Flovent's discontinuation is killing children with asthma

Midwives could help bridge maternal health disparities in the U.S.

focus

Wikipedia

knowledge

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Fertility clinic egg and embryo storage is a disaster

Malaria cases in Florida and Texas: Here’s what you need to know

Why the drug industry's warnings on the IRA's impact fall short

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Novo Nordisk testing Wegovy against alcohol

Continuity nursing helped my family in our darkest PICU moments

FDA panel to weigh safety of artificial wombs for preterm births

After affirmative action ruling, medical educators look to 'holistic review'

WuXi Biologics execs register to lobby as Congress comes for the company

explore

Lilly’s weekly insulin works as well as daily products, new studies show

Cherokee Nation medical school graduates its first class

Galapagos to make CAR

Transgender sports debate: Physicians say bans are health issue

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Why the drug industry's warnings on the IRA's impact fall short

Wikipedia

entertainment

hotspot

focus